Full text is available at the source.
Abstract
Repeated intravenous ketamine infusions may provide insights into treatment-resistant bipolar depression.
- The findings aim to contextualize the effects of ketamine on individuals with treatment-resistant bipolar depression.
- There is a focus on identifying priorities that could enhance the safety of ketamine infusions in clinical settings.
- The research seeks to understand how to achieve more durable outcomes for patients undergoing this treatment.
Simplified